Lynch Syndrome: Symptoms, Causes & Ayurvedic Care

ABSTRACT

Lynch syndrome is an inherited genetic disorder that increases the risk of developing colorectal, endometrial, ovarian, gastric, urinary tract, and several other cancers. It commonly results from pathogenic changes in DNA mismatch repair genes, including MLH1, MSH2, MSH6, PMS2, and EPCAM. Individuals with Lynch syndrome may develop cancer at a younger age and can have an increased risk of multiple primary malignancies. Identification of affected individuals through personal and family history, genetic testing, and appropriate screening is important for early detection and risk reduction. Regular surveillance, genetic counselling, and individualized preventive strategies form the foundation of long-term management.

INTRODUCTION

Lynch syndrome is a hereditary cancer predisposition condition caused by inherited alterations in genes responsible for correcting DNA replication errors. It is one of the most common inherited causes of colorectal cancer and is also associated with malignancies of the endometrium, ovaries, stomach, small intestine, urinary tract, and other organs. Unlike sporadic cancers, tumors associated with Lynch syndrome can occur at relatively younger ages and may affect more than one family member across generations. Recognizing the characteristic pattern of cancers within a family helps identify individuals who require genetic evaluation and closer surveillance. Early identification allows timely screening and appropriate preventive care.

STASTATICS ABOUT LYNCH SYNDROME

• Prevalence: Lynch syndrome affects approximately 1 in 279 people worldwide.
• Colorectal cancer: It contributes to around 2–5% of colorectal cancer cases.
• Endometrial cancer: Approximately 3% of endometrial cancers are linked to Lynch syndrome.
• Lifetime colorectal cancer risk: Risk varies by gene and can reach approximately 40–50% or higher for some MLH1 and MSH2 carriers.
• Age of onset: Lynch syndrome-associated cancers often develop before 50 years of age.
• Multiple cancers: It increases the risk of colorectal, endometrial, ovarian, gastric,urinary tract, and several other cancers.
• Gene variation: Cancer risk differs considerably among MLH1, MSH2, MSH6, PMS2, and EPCAM carriers.

INTERESTING FACT ABOUT LYNCH SYNDROME

• Lynch syndrome is inherited: A person with a disease-causing variant has a 50% chance of passing it to each child.
• It can affect multiple organs: Besides the colon and rectum, it can increase the risk of endometrial, ovarian, stomach, urinary tract, and other cancers.
• Cancer can occur at a younger age: Lynch syndrome-related cancers often appear earlier than many sporadic cancers.
• Several genes are involved: The main genes include MLH1, MSH2, MSH6, PMS2, and EPCAM.
• Family history can provide an important clue: Multiple relatives with colorectal or endometrial cancer, particularly at younger ages, can suggest an inherited cancer syndrome.
• Tumor testing can help identify risk: Mismatch repair (MMR) protein testing and microsatellite instability (MSI) testing are commonly used to identify tumors that may be associated with Lynch syndrome.
• One person can develop more than one cancer: Lynch syndrome increases the possibility of multiple primary cancers during a lifetime.
• Early identification matters: Genetic counselling and appropriate surveillance can help identify cancers at an earlier stage and guide preventive care.

CAUSES OF LYNCH SYNDROME

• Inherited gene mutations: Lynch syndrome primarily occurs due to inherited pathogenic variants in DNA mismatch repair genes such as MLH1, MSH2, MSH6, and PMS2, or alterations affecting EPCAM.
• Defective DNA repair: These genetic changes impair the bodys ability to correct errors that occur when DNA is copied, allowing abnormal cells to accumulate genetic changes.
• Autosomal dominant inheritance: A pathogenic variant in one copy of the affected gene can be sufficient to increase cancer susceptibility and can be passed from an affected parent to a child.
• Family transmission: A person with Lynch syndrome generally has a 50% chance of passing the altered gene to each biological child.
• Somatic changes: Additional changes acquired within cells can contribute to tumor development after the inherited mutation is already present.
• Not caused by lifestyle alone: Lynch syndrome is fundamentally a hereditary genetic condition, although environmental and lifestyle factors can influence overall cancer risk.

SIGNS AND SYMPTOMS OF LYNCH SYNDROME

Lynch syndrome itself often does not produce specific symptoms because it is an inherited genetic condition that increases the risk of certain cancers. Symptoms usually appear when an associated cancer develops.

• Changes in bowel habits – persistent constipation, diarrhea, or alternating bowel patterns.
• Blood in stool – visible blood or dark, tarry stools.
• Unexplained abdominal pain – recurrent cramps, discomfort, or bloating.
• Unexplained weight loss – weight reduction without changes in diet or physical activity.
• Persistent fatigue – tiredness that can occur with chronic blood loss or cancer.
• Iron-deficiency anemia – particularly when caused by hidden gastrointestinal bleeding.
• Rectal discomfort or changes in stool caliber – narrower stools or persistent urgency.
• Abnormal uterine bleeding – unusually heavy, irregular, or postmenopausal bleeding can occur with endometrial cancer.
• Pelvic pain – persistent pelvic or lower abdominal discomfort may occur with gynecological cancers.
• Urinary changes – blood in urine, frequent urination, or painful urination can occur with urinary tract cancers associated with Lynch syndrome.
• Unexplained nausea or reduced appetite – can accompany some gastrointestinal cancers.
• Jaundice or persistent upper abdominal discomfort – uncommon, but possible with certain Lynch-associated cancers.
• Symptoms may occur at a younger age – cancers linked with Lynch syndrome can develop earlier than those seen in the general population.

DIAGNOSIS OF LYNCH SYNDROME

Lynch syndrome is diagnosed through a combination of personal or family cancer history, tumor testing, and genetic testing. Important diagnostic approaches include:

• Detailed personal and family history: Assessment of colorectal, endometrial, ovarian, gastric, urinary tract, and other Lynch-associated cancers, particularly when they occur at a young age or in several relatives.
• Tumor screening: Tumor tissue from colorectal or endometrial cancer can be evaluated for evidence of mismatch repair deficiency.
• Immunohistochemistry (IHC): This test checks the tumor for the presence of the mismatch repair proteins MLH1, MSH2, MSH6, and PMS2. Loss of one or more proteins can indicate possible Lynch syndrome.
• Microsatellite instability (MSI) testing: Tumor DNA is examined for changes in microsatellite regions. MSI-high results can suggest defective mismatch repair and raise suspicion of Lynch syndrome.
• MLH1 promoter methylation testing: When MLH1 protein is absent, methylation testing helps distinguish sporadic tumors from those caused by an inherited MLH1 mutation.
• BRAF testing: In colorectal tumors with loss of MLH1, the presence of a BRAF V600E alteration can support a sporadic rather than inherited cause.
• Germline genetic testing: A blood or saliva sample can be tested for inherited pathogenic variants in mismatched repair genes, mainly MLH1, MSH2, MSH6, PMS2, and EPCAM.
• Genetic counselling: Genetic counselling before and after testing helps explain the implications of the results and assists with appropriate testing of at-risk family members.
• Family testing: If a pathogenic germline variant is identified, relatives can undergo targeted testing to determine whether they carry the same inherited variant.
• Clinical diagnostic criteria: Amsterdam II criteria and revised Bethesda guidelines can help identify individuals who should undergo further evaluation, although modern practice increasingly relies on tumor screening and germline testing.
• Colonoscopy and other surveillance investigations: These do not confirm Lynch syndrome but are important for detecting colorectal and other associated cancers in individuals suspected or confirmed to have the condition.

MANAGEMENT OF LYNCH SYNDROME

Lynch syndrome cannot currently be eliminated because it results from an inherited pathogenic variant. Management therefore focuses on early cancer detection, risk reduction, appropriate treatment, and family screening.

• Genetic counselling: Individuals diagnosed with Lynch syndrome should receive genetic counselling to understand cancer risks, inheritance patterns, testing options, and implications for family members.
• Regular colonoscopy: Periodic colonoscopic surveillance is one of the most important measures for reducing the risk of advanced colorectal cancer. The starting age and interval should be individualized according to the affected gene and family history.
• Endometrial cancer surveillance: Women with Lynch syndrome should discuss appropriate monitoring for endometrial cancer. Any abnormal uterine bleeding, particularly after menopause, requires prompt evaluation.
• Ovarian cancer awareness: Women should be educated about symptoms such as persistent pelvic discomfort, abdominal bloating, or unexplained changes in bowel or urinary habits. Risk-reducing surgery may be considered in selected individuals after completion of childbearing.
• Upper gastrointestinal surveillance: Periodic upper gastrointestinal endoscopy may be recommended for selected individuals, particularly those with specific genetic or family-risk factors.
• Urinary tract monitoring: People with relevant family or genetic risk should discuss surveillance for urothelial cancers with their healthcare provider, especially when there is a strong family history.
• Risk-reducing surgery: In selected women who have completed childbearing, removal of the uterus and ovaries may substantially reduce the risk of endometrial and ovarian cancers.
• Aspirin consideration: Aspirin has been investigated for colorectal cancer risk reduction in Lynch syndrome. Its use should be discussed with a healthcare professional because the appropriate dose and duration depend on individual factors and bleeding risk.
• Healthy lifestyle: Maintaining a healthy body weight, exercising regularly, avoiding tobacco, limiting alcohol, and following a balanced diet can support overall health and reduce additional cancer risk factors.
• Prompt evaluation of warning signs: Persistent changes in bowel habits, rectal bleeding, unexplained weight loss, anemia, abnormal uterine bleeding, or blood in the urine should be medically evaluated without delay.
• Treatment of detected cancers: If cancer develops, treatment is selected according to the cancer type, stage, molecular characteristics, and overall health. Surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy may be considered where appropriate.
• Family screening: First-degree relatives may benefit from genetic counselling and targeted genetic testing when a pathogenic variant has been identified in the family.
• Long-term follow-up: Lifelong surveillance is important because Lynch syndrome increases the risk of developing more than one Lynch-associated cancer during a persons lifetime.

AYURVEDIC INSIGHTS OF LYNCH SYNDROME

Ayurveda does not describe Lynch syndrome as a specific disease entity or provide a method to correct its underlying genetic alteration. However, its principles can be considered as supportive measures for maintaining overall health and improving individual resilience alongside appropriate medical surveillance. From an Ayurvedic perspective, attention is given to Agni (digestive fire) , Dosha status, Ahara ( diet) Vihara( lifestyle) and regular elimination. Digestive irregularities, improper dietary habits, inadequate sleep, sedentary behavior, and prolonged mental stress are traditionally considered factors that can disturb physiological functioning. An individualized approach may therefore include easily digestible and nutrient-rich foods, adequate hydration, regular physical activity, proper sleep, stress- management practices, and suitable Dinacharya. Ayurvedic formulations or therapies should be selected according to Prakriti, Vikriti, age, strength, digestion, and individual requirements.

SAMPRAPATI (PATHOGENESIS) OF LYNCH SYNDROME

CHIKITSA (MANAGEMENT)

• Nidana Parivarjana: Avoid processed foods, excessive fried foods, alcohol, overeating and irregular meals. Maintain a wholesome, easily digestible diet.
• Agni Deepana & Ama Pachana: Maintain healthy Jatharagni and prevent Ama (endotoxins) formation. Herbs such as Shunthi (Zingiber officinale), Pippali (Piper longum) and Guduchi (Tinospora cordifolia) can be considered according to individual assessment.
• Srotas Support: Give attention to Annavaha and Purishavaha Srotas by maintaining proper digestion and regular bowel habits.
• Rasayana Chikitsa: Selected Rasayana herbs such as Amalaki (Phyllanthus emblica), Guduchi (Tinospora cordifolia) and Ashwagandha (Withania somnifera) can be considered for general strength and wellbeing.
• Bala and Ojas Support: Adequate nutrition, hydration, proper sleep and suitable physical activity help maintain Bala and overall vitality.
• Manasika Chikitsa: Yoga, meditation, Pranayama and adequate rest can support mental wellbeing, particularly because Lynch syndrome requires long-term surveillance.
• Panchakarma: Strong Panchakarma should not be routinely advised in Lynch syndrome. If considered, it should depend on the patients strength, symptoms and current cancer treatment.
• Cancer Surveillance: Regular colonoscopy, genetic counselling and appropriate screening for associated cancers are essential. Ayurveda should be used as supportive care and not as a replacement for cancer surveillance or indicated oncology treatment.

HERBAL REMEDIES USED BY PLANET AYURVEDA

Planet Ayurveda is a well-established Ayurvedic healthcare organization that works to promote the ancient knowledge of Ayurveda through natural remedies and holistic health solutions. The company develops a wide range of herbal formulations using pure, high- quality ingredients and standardized herbal extracts, with a focus on maintaining safety, authenticity, and effectiveness. Following the principles of classical Ayurveda, Planet Ayurveda aims to support overall health by addressing the underlying causes of health concerns and encouraging balance in the body, mind, and emotions. With an emphasis on quality, natural ingredients, and traditional approaches supported by modern research, the organization works toward making Ayurvedic wellness solutions available globally. Planet Ayurveda offers various Ayurvedic formulations that are designed to use in Lynch Syndrome.The formulation are;

1. Crab Curcumin 95% Capsules
2. Tumotrim Capsules
3. Amalaki Rasayan Capsules
4. Chandraparabha Vati
5. Ashwangandha Capsules

Lynch Syndrome

PRODUCT DESCRIPTION

1. CRAB CURCUMIN 95% CAPSULES

It contains Haridra (Curcuma longa) and Maricha (Piper nigrum), providing concentrated curcumin along with piperine. Haridra is traditionally valued for its Deepan (increased digestive fire), Pachana (digest the food) and Rasayana (increasing strength) properties and supports healthy inflammatory and cellular functions. Maricha supports digestion and enhances the bioavailability of curcumin. In Lynch syndrome, this formulation may be included as part of a broader supportive approach focused on maintaining digestion, metabolic wellbeing and cellular health.

Dosage – 1 Capsule twice a day after a meal.

2. TUMOTRIM CAPSULES

It contains Shunthi (Zingiber officinale), Maricha (Piper nigrum), Haridra (Curcuma longa), Ashwagandha (Withania somnifera), along with several other herbal ingredients. These herbs are traditionally valued for supporting Agni, digestion, Rasayana functions and overall vitality. The formulation can complement a wellness approach focused on maintaining metabolic and cellular health.

Dosage– 1 Capsule twice a day after a meal.

3. AMALAKI RASAYAN CAPSULES

Its key ingredient is Amalaki (Phyllanthus emblica), a well-known Rasayana (increasing strength) herb traditionally valued for supporting digestion, nourishment and overall vitality. Amalaki is rich in naturally occurring antioxidant compounds and can support healthy cellular function and general weakness.

Dosage -2 Capsules twice a day after a meal.

4. CHANDRAPRABHA VATI

Chandra Prabha Vati can be included as a supportive Ayurvedic formulation in the overall wellness management of individuals with Lynch syndrome. It contains herbs such as Vacha (Acorus calamus), Mustak (Cyperus rotundus), Haridra (Curcuma longa), Amalaki (Emblica officinalis), Chavya (Piper chaba), Vidanga (Embelia ribes), Guduchi (Tinospora cordifolia), and Shunthi (Zingiber officinale), along with other classical ingredients including Karpoor. These ingredients are traditionally used to support Agni, digestion, metabolism and overall vitality. Haridra, Amalaki and Guduchi are also valued for their antioxidant and Rasayana properties.

Dosage – 2 Tablets twice a day after a meal.

5. ASHWAGANDHA CAPSULES

The formulation contains Ashwagandha (Withania somnifera), a renowned Rasayana herb traditionally used to support Bala, Ojas, vitality and healthy stress response. Ashwagandha also provides naturally occurring bioactive compounds with antioxidant properties that support overall cellular wellness. In individuals with Lynch syndrome, maintaining strength, nutrition, digestion and general wellbeing is an important part of supportive care.

Dosage -1 Capsule twice a day after a meal.

CONCLUSION

Lynch syndrome is an inherited condition associated with a higher lifetime risk of developing colorectal, endometrial and certain other cancers due to alterations in DNA mismatch repair genes. Because the genetic predisposition remains throughout life, early detection, regular surveillance, genetic counselling and appropriate medical management are the most important components of care. Colonoscopic screening and other examinations should be planned according to the affected gene, family history and individual risk.From an Ayurvedic perspective, Lynch syndrome does not have a direct classical disease equivalent. Its management can therefore be approached through individualized supportive principles such as Nidana Parivarjana (causative factors), Agni (digestive fire) Deepana (increasing digestive fire) Ama Pachana, Srotas support, Rasayana Chikitsa and Bala-Ojas nourishment. Proper diet, regular bowel habits, adequate sleep, physical activity and stress-management practices can contribute to overall wellbeing. Selected Ayurvedic herbs and formulations may be considered according to Prakriti, Agni, Bala and clinical conditions.Ayurveda can provide supportive care aimed at maintaining digestion, strength, nutrition and quality of life, but it cannot remove the inherited genetic predisposition responsible for Lynch syndrome.